HER2-Induced MMP-1 Expression Is Mediated by HER1 Though AR, EGF, and TGF Independent of HER3 through HRG in Breast Cancer Cells

被引：0
|
作者：
Jung, H. H. [1 ]
Park, Y. H. [1 ]
Ahn, J. S. [1 ]
Im, Y-H. [1 ]
机构：
[1] Samsung Med Ctr Trastuzumab, Seoul, South Korea
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P5-05-13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-05-13
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin
    Marcia R. Campbell
    Hui Zhang
    Shabnam Ziaee
    Ana Ruiz-Saenz
    Nathaniel Gulizia
    Julie Oeffinger
    Dhara N. Amin
    Deepika Ahuja
    Mark M. Moasser
    Catherine C. Park
    [J]. Breast Cancer Research and Treatment, 2016, 155 : 431 - 440
  • [22] Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin
    Campbell, Marcia R.
    Zhang, Hui
    Ziaee, Shabnam
    Ruiz-Saenz, Ana
    Gulizia, Nathaniel
    Oeffinger, Julie
    Amin, Dhara N.
    Ahuja, Deepika
    Moasser, Mark M.
    Park, Catherine C.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (03) : 431 - 440
  • [23] Quantification of HER1, HER2 and HER3 by time-resolved Förster resonance energy transfer in FFPE triple-negative breast cancer samples
    Alexandre Ho-Pun-Cheung
    Hervé Bazin
    Florence Boissière-Michot
    Caroline Mollevi
    Joëlle Simony-Lafontaine
    Emeline Landas
    Jean-Pierre Bleuse
    Thierry Chardès
    Jean-François Prost
    André Pèlegrin
    William Jacot
    Gérard Mathis
    Evelyne Lopez-Crapez
    [J]. British Journal of Cancer, 2020, 122 : 397 - 404
  • [24] The influence of hormone receptor status and HER1 and HER2 expression on the response to neoadjuvant therapy in breast cancer patients
    Bouiglieri, L.
    Torrisi, R.
    Pruneri, G.
    Colleoni, M.
    Viale, G.
    [J]. MODERN PATHOLOGY, 2008, 21 : 24A - 24A
  • [25] The influence of hormone receptor status and HER1 and HER2 expression on the response to neoadjuvant therapy in breast cancer patients
    Bonigliere, L.
    Torrisi, R.
    Pruneri, G.
    Colleoni, M.
    Viale, G.
    [J]. LABORATORY INVESTIGATION, 2008, 88 : 24A - 24A
  • [26] Co-expression of HER3 in HER2-positive metastatic breast cancer patients is an independent predictor of impaired prognosis
    Berghoff, A. S.
    Bago-Horvath, Z.
    Preusser, M.
    Steger, G. G.
    Rudas, M.
    Birner, P.
    Zielinski, C. C.
    Bartsch, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S421 - S421
  • [27] CLINICAL UTILITY OF THE EXPRESSION OF HER3, HER4, PTEN AND IGF1R IN HER2-POSITIVE ADVANCED OR METASTATIC BREAST CANCER
    Ito, Hiroki
    Ueno, Takayuki
    Isaka, Hirotsugu
    Miyamoto, Kaisuke
    Imoto, Shigeru
    [J]. BREAST, 2015, 24 : S66 - S66
  • [28] HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion
    Bao, Wei
    Fu, Hai-Jing
    Jia, Lin-Tao
    Zhang, Yong
    Li, Wei
    Jin, Bo-Quan
    Yao, Li-Bo
    Chen, Si-Yi
    Yang, An-Gang
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2010, 499 (1-2) : 49 - 55
  • [29] Breast cancer and Epstein-Barr virus: latent membrane protein 1 homology with the HER family (HER1, 2, 3 and 4)
    Tran, M. K. G.
    Boire, J. Y.
    [J]. BULLETIN DU CANCER, 2008, 95 (06) : 584 - 584
  • [30] Real-time fluorescent quantitative PCR reveals increased HER2, HER3, and unchanged HER1 (EGFR) mRNA expression levels in colon carcinomas.
    Calvo, B
    Caskey, L
    Earp, HS
    [J]. CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3761S - 3761S
12345